and advisory boards across the region. Drive internal cultural change toward EdwardsLifesciences patient-first values... and safeguarding Edwards’ reputation and brand identity, our Public Affairs teams build and maintain valued partnerships across the...
, Valencia. When it becomes operational in 2026, the plant will manufacture Edwards' surgical and transcatheter heart valve... software tools Solid knowledge and understanding of Edwards policies, procedures, and regulatory (e.g., medical...
Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technol...
, Valencia. When it becomes operational in 2026, the plant will manufacture Edwards' surgical and transcatheter heart valve... of quality engineering principles and methods to ensure compliance with regulatory requirements and Edwards' systems/procedures...